Rifampicin use in MRSA infections: will it add to the emergence of multidrug-resistant tuberculosis in developing countries?
Neogi
Devdatta Suhas
DS
Yadav
Chandra Shekhar
CS
Vonnum
Phani Madhuri
PM
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D003906:Developing Countries; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D012293:Rifampin / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology* / Q000209:etiology
D000904:Antibiotics, Antitubercular; D012293:Rifampin